ASX
Botanix Pharmaceuticals Ltd
BOT:ASX•Healthcare
Sensitive ASX Announcement
Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
Published: 13/10/22, 09:47am (AEST)•17 pages